Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec;26(12):1617-1618.
doi: 10.18553/jmcp.2020.26.12.1617.

THE AUTHORS RESPOND

Joshua A Roth  1 , Josh J Carlson  2 , Fang Xia  3 , Todd Williamson  3 , Sean D Sullivan  4
Affiliations
Comment

THE AUTHORS RESPOND

Joshua A Roth et al. J Manag Care Spec Pharm. 2020 Dec.

Abstract

DISCLOSURES: Funding for the study referred to in this letter was contributed by Bayer Healthcare. Xia and Williamson are employees of Bayer Healthcare. Roth, Carlson, and Sullivan are consultants to Bayer Healthcare. Carlson also reports fees from Adaptive Biotechnologies, unrelated to the study. Roth reports consulting fees from BMS, unrelated to the study.

PubMed Disclaimer

Conflict of interest statement

Funding for the study referred to in this letter was contributed by Bayer Healthcare. Xia and Williamson are employees of Bayer Healthcare. Roth, Carlson, and Sullivan are consultants to Bayer Healthcare. Carlson also reports fees from Adaptive Biotechnologies, unrelated to the study. Roth reports consulting fees from BMS, unrelated to the study.

Comment on

References

    1. Roth JA, Carlson JJ, Xia F, Williamson T, Sullivan SD. The potential long-term comparative effectiveness of larotrectinib and entrectinib for second-line treatment of TRK fusion-positive metastatic lung cancer. J Manag Care Spec Pharm. 2020;26(8):981-86. doi: 10.18553/jmcp.2020.20045 - PMC - PubMed
    1. Journal of Managed Care and Specialty Pharmacy. JMCP author guidelines. Updated March 2020. Accessed November 12, 2020. https://www.jmcp.org/authorguidelines